Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation.
D000818:Animals; D002346:Carotid Sinus / Q000502:physiology; D003326:Coronary Circulation; D004285:Dogs; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D010643:Phenoxybenzamine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000502:physiology*; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D014661:Vasoconstriction; D014664:Vasodilation
D010879:Piperazines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D010643:Phenoxybenzamine; D010100:Oxygen; D009638:Norepinephrine